Ophthalmology and Ocular Surface Disease
Biotechnology Institute I Mas D S.L. supports clinical research in dry eye disease and related ophthalmic conditions, including patients with glaucoma. Its trial portfolio focuses on PRGF eye drops for relieving ocular discomfort and improving tear film symptoms.
- Dry eye disease
- Glaucoma
- PRGF eye drops
The sponsor’s eye-related studies examine both symptom control and treatment tolerance in chronic ocular surface disorders.
Wound Healing and Diabetic Foot Ulcers
The company funds research in diabetic foot ulcer management, with attention to patients who also have peripheral arterial disease. These studies center on plasma rich in growth factors in the context of impaired tissue repair.
- Foot ulcers in diabetic patients
- Peripheral arterial disease
- Wound healing
Its clinical interest in this area is directed toward ulcer evolution and recovery in complex metabolic and vascular disease.
Musculoskeletal Pain and Spinal Disorders
Biotechnology Institute I Mas D S.L. also investigates low back pain associated with lumbar disc degeneration. The sponsored research evaluates regenerative approaches for pain relief and functional improvement in chronic spinal conditions.
- Low back pain
- Lumbar disc degeneration
- Quality of life
This area reflects an interest in persistent musculoskeletal symptoms where conventional pain management remains a clinical need.
Regenerative Medicine with PRGF
Across its trial portfolio, the sponsor focuses on plasma rich in growth factors as a therapeutic platform in ophthalmology, wound care, and pain management. The funded studies explore its use in tissue repair and symptom reduction across distinct clinical settings.
- Plasma rich in growth factors (PRGF)
- Regenerative therapy
- Tissue repair
The research activity spans chronic conditions where biologically based treatments are being assessed for therapeutic benefit.



